Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 15]
PHARMAC devices savings to help hospitals manage budgets
Tuesday, 5 July 2016, 11:05 am | PHARMAC
New data from PHARMAC is predicting DHB hospital spending on surgical and medical devices will fall by about $25 million over coming years. And this is set to grow with a consultation released today that, if implemented, would save a further $3.2 ... More >>
Health sector feedback helps make the most of funding boost
Thursday, 9 June 2016, 2:25 pm | PHARMAC
PHARMAC is today announcing funding of six new treatments across important areas of health, including major advancements in the treatment of hepatitis C. More >>
PHARMAC seeking new Māori members for consumer committee
Tuesday, 23 February 2016, 10:40 am | PHARMAC
PHARMAC is seeking nominations for two Māori members of its Consumer Advisory Committee (CAC). More >>
New treatment options for patients with multiple sclerosis
Wednesday, 9 December 2015, 2:19 pm | PHARMAC
Funding for two new medicines will provide patients with more convenient options for treating multiple sclerosis. More >>
NZers getting access to best cancer medicines
Tuesday, 3 November 2015, 4:12 pm | PHARMAC
A new analysis of cancer medicine access in Australia and New Zealand shows that New Zealanders are getting access to the best cancer medicines available, says PHARMAC medical director Dr John Wyeth. More >>
Pharmac welcomes appointments to clinical committee
Friday, 17 July 2015, 10:31 am | PHARMAC
Pharmac welcomes appointments to clinical committee Pharmac medical director Dr John Wyeth is welcoming the appointment of a new Chair and two new members to the Pharmacology and Therapeutics Advisory Committee (PTAC). PTAC is a statutory committee ... More >>
New leadership, new members for PHARMAC consumer committee
Thursday, 9 July 2015, 10:17 am | PHARMAC
New leadership, new members for PHARMAC consumer committee Wellington smoking cessation advocate Shane Bradbrook has been appointed chair of PHARMAC’s Consumer Advisory Committee. Shane Bradbrook, a member of the Committee since 2010, will succeed Kate ... More >>
Moves to protect availability of haemophilia treatments
Monday, 6 July 2015, 3:45 pm | PHARMAC
In changes to take effect from 1 September, PHARMAC is moving to have a preferred brand of recombinant Factor VIII, while also maintaining full funding for the other three currently-funded haemophilia products. More >>
PHARMAC Moving to Next Stage of Medical Devices Activity
Tuesday, 14 April 2015, 11:17 am | PHARMAC
PHARMAC is now consulting on moving to the next stage in its hospital medical devices work – market share procurement. This next stage of activity would see PHARMAC offering suppliers an assured portion of the market in return for competitive pricing ... More >>
PHARMAC tender savings top $600 million
Tuesday, 17 March 2015, 11:41 am | PHARMAC
Estimated savings achieved through PHARMAC’s tender of off-patent medicines have now topped $600 million. PHARMAC has run a tender for off-patent medicines since 1997. The tender promotes competition among pharmaceutical companies to bid for sole ... More >>
PHARMAC in negotiations over rare disorders medicines
Friday, 27 February 2015, 9:03 am | PHARMAC
PHARMAC is in active negotiations with several suppliers as a result of its competitive process for rare disorders medicines. On the eve of World Rare Diseases Day, PHARMAC has announced that 28 proposals from eight suppliers emerged from its request for ... More >>
PHARMAC secures significant savings for DHBs
Thursday, 4 December 2014, 2:57 pm | PHARMAC
A new agreement for a high cost biologic drug will yield considerable savings for DHBs over the next five years, says PHARMAC. Infliximab is a monoclonal antibody, one of the so-called `targeted drugs’ used to treat auto-immune conditions like ... More >>
PHARMAC expands into new medical device category
Monday, 3 November 2014, 2:27 pm | PHARMAC
DHBs are expected to start making further savings in cardiac medical devices, after PHARMAC extended the range of products it already has under national contracts by beginning listing those used in cardiac procedures. More >>
PHARMAC approves largest single deal
Tuesday, 14 October 2014, 9:56 am | PHARMAC
Nearly 12,000 New Zealanders are set to benefit from major agreements that have been approved by PHARMAC. Agreements with two companies, Novartis and Biogen Idec, have been approved which will see 10 new medicines funded, and either reduced prices or ... More >>
Tender for generic medicines contributes $38 million savings
Monday, 18 August 2014, 3:25 pm | PHARMAC
New Zealanders’ use of generic medicines is likely to grow further following the just-completed 2013/14 PHARMAC tender. The tender reached record levels this year, receiving nearly 3500 offers to supply pharmaceuticals from 54 companies. More >>
Savings for DHBs in medical equipment agreement
Friday, 15 August 2014, 10:54 am | PHARMAC
DHBs will save another $650,000 a year from lower priced wound care and surgery equipment through a new national PHARMAC agreement with a major medical device supplier. More >>
PHARMAC welcomes updated Medicines NZ Code of Practice
Wednesday, 13 August 2014, 9:57 am | PHARMAC
PHARMAC is welcoming the publication of an updated Medicines NZ Code of Practice (COP). The Code, now in its 16th edition, has been updated following feedback from stakeholders in the pharmaceutical sector, including PHARMAC. Chief executive Steffan ... More >>
PHARMAC looks to Pasifika community for advisory committee
Wednesday, 16 July 2014, 3:11 pm | PHARMAC
PHARMAC has appointed three new members to its Consumer Advisory Committee (CAC), all with strong links to the Pasifika community. More >>
Two new appointments to PHARMAC advisory committee
Wednesday, 18 June 2014, 10:04 am | PHARMAC
PHARMAC is welcoming the appointment of two new members to the Pharmacology and Therapeutics Advisory Committee (PTAC). PTAC provides PHARMAC with expert clinical advice on pharmaceutical funding applications being considered by PHARMAC, and other ... More >>
New treatment funded for severe gout
Wednesday, 21 May 2014, 2:24 pm | PHARMAC
New treatment funded for severe gout Patients with severe gout will soon have a new treatment option as PHARMAC will be funding febuxostat (Adenuric) from 1 June 2014. Gout is a painful form of arthritis, and is associated with high levels of uric acid ... More >>
